ZDV-11701-20421
5 vaccinations
18 coded responses
61 check-ins
17 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 496 / MI
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Pfizer-BioNTech
- 2020-12-29
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2020-12-31
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-14
-
2021-01-19
Dose 2 — Pfizer-BioNTech
- 2021-01-19
-
2021-01-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-01-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-01-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Abdominal painAdult check-in
-
2021-01-26
Health check-in — day 7, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-02-02
-
2021-02-09
Survey response — day 21, dose 2MedDRA: Abdominal discomfort, Diarrhoea — Feeling: GoodFree text: Some GI distress including loose stools.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-04-20
- 2021-07-20
-
2021-10-04
Dose 3 — Pfizer-BioNTech
- 2021-10-04
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Chills, Abdominal painAdult check-in
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-10-08
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, Abdominal painAdult check-in
- 2021-10-09
-
2021-10-10
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-10-11
- 2021-10-18
-
2021-10-25
Survey response — day 21, dose 3MedDRA: Headache, Nausea, Pyrexia — Feeling: Fair · Be unable to work or attend schoolFree text: Headache, nausea, and low grade feverMedDRA releases: 2024-11 · check-in free text available
-
2021-11-01
Survey response — day 28, dose 3MedDRA: Body temperature increased — Feeling: GoodFree text: Periodic short lasting low grade fevers of ~ 100.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-08
Survey response — day 35, dose 3MedDRA: Fatigue, Oropharyngeal pain, Respiratory tract congestion — Feeling: FairFree text: Very sore throat and some head congestion; fatigueMedDRA releases: 2024-11 · check-in free text available
- 2021-11-15
-
2022-01-03
Survey response — 3 months, dose 3MedDRA: Oropharyngeal pain, Sinusitis — Feeling: FairFree text: Probable lingering sinus infection; sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-04-04
Survey response — 6 months, dose 3MedDRA: Pre-existing disease, Tinnitus — Feeling: GoodFree text: Existing tinnitus has exacerbatedMedDRA releases: 2024-11 · check-in free text available
-
2022-04-27
Dose 4 — Pfizer-BioNTech
-
2022-04-29
Survey response — days 1–6 daily, dose 4MedDRA: Adverse reaction — Feeling: Good · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: These were significant in the first 24-36 hoursMedDRA releases: 2024-11 · check-in free text available
-
2022-04-30
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Headache, Joint painsAdult check-in
-
2022-05-01
Survey response — days 1–6 daily, dose 4MedDRA: Epistaxis — Feeling: Fair · Site: Pain · Fever · HeadacheFree text: Nose bleedMedDRA releases: 2024-11 · check-in free text available
- 2022-05-02
-
2022-05-03
Survey response — days 1–6 daily, dose 4MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Slight sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-05-04
- 2022-05-11
- 2022-05-18
-
2022-05-26
Survey response — day 28, dose 4MedDRA: Cough — Feeling: GoodFree text: Dry coughMedDRA releases: 2024-11 · check-in free text available
- 2022-06-01
-
2022-06-08
Survey response — day 42, dose 4MedDRA: Epistaxis — Feeling: GoodFree text: Another spontaneous nosebleed.MedDRA releases: 2024-11 · check-in free text available
- 2022-07-27
-
2022-10-26
Survey response — 6 months, dose 4MedDRA: Epistaxis — Feeling: FairFree text: Occasional unprovoked nosebleeds.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-10
Dose 5 — Pfizer-BioNTech
- 2022-11-15
-
2022-11-16
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2022-11-17
Health check-in — day 7, dose 5Feeling: Fair · Fever · Headache, Fatigue or tirednessAdult check-in
-
2022-11-24
Survey response — day 14, dose 5MedDRA: Fatigue, Oropharyngeal pain — Feeling: FairFree text: Sore throat and fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-12-01
Survey response — day 21, dose 5MedDRA: Epistaxis, Oropharyngeal pain, Pyrexia — Feeling: FairFree text: Sore throat. Short lived fevers. I continue to have weekly unprovoked nosebleeds.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-08
Survey response — day 28, dose 5MedDRA: Condition aggravated, Pre-existing disease — Feeling: GoodFree text: Nose bleeds are more frequent.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-15
Survey response — day 35, dose 5MedDRA: Epistaxis — Feeling: GoodFree text: Nosebleeds continue and are more frequent.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-22
Survey response — day 42, dose 5MedDRA: Gastrointestinal disorder, Oropharyngeal pain, Respiratory tract congestion — Feeling: FairFree text: Moderate sore throat and congestion, some GI issues.MedDRA releases: 2024-11 · check-in free text available
- 2023-02-09
-
2023-05-11
Survey response — 6 months, dose 5MedDRA: COVID-19, Cough, Diarrhoea, Dyspnoea, Epistaxis, Fatigue, Oropharyngeal pain, Pain, Parosmia, Pyrexia, Respiratory tract congestion, Sneezing, Taste disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-05-11
Report sent to call center — 6 months, dose 5Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-05-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
| 4 | 2022-04-27 | Pfizer-BioNTech | No |
| 5 | 2022-11-10 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-05-11 | Unsuccessful |
Free text
Release 3 — day 21, dose 2
Symptoms: Some GI distress including loose stools.
Release 10 — day 21, dose 3
Symptoms: Headache, nausea, and low grade fever
Release 10 — day 28, dose 3
Symptoms: Periodic short lasting low grade fevers of ~ 100.
Release 10 — day 35, dose 3
Symptoms: Very sore throat and some head congestion; fatigue
Release 10 — 3 months, dose 3
Symptoms: Probable lingering sinus infection; sore throat
Release 11 — 6 months, dose 3
Symptoms: Existing tinnitus has exacerbated
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): These were significant in the first 24-36 hours
Systemic reaction (other): Nose bleed
Systemic reaction (other): Slight sore throat
Release 11 — day 28, dose 4
Symptoms: Dry cough
Release 11 — day 42, dose 4
Symptoms: Another spontaneous nosebleed.
Release 12 — 6 months, dose 4
Symptoms: Occasional unprovoked nosebleeds.
Release 12 — day 14, dose 5
Symptoms: Sore throat and fatigue
Release 12 — day 21, dose 5
Symptoms: Sore throat. Short lived fevers. I continue to have weekly unprovoked nosebleeds.
Release 12 — day 28, dose 5
Symptoms: Nose bleeds are more frequent.
Release 12 — day 35, dose 5
Symptoms: Nosebleeds continue and are more frequent.
Release 12 — day 42, dose 5
Symptoms: Moderate sore throat and congestion, some GI issues.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | ✓ | ✓ | ✓ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Epistaxis | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Parosmia | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Taste disorder | · | · | ✓ |
| SD | Tinnitus | · | · | ✓ |
| SRO | Adverse reaction | · | · | ✓ |
| SRO | Epistaxis | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release